ArticleOrthopaedic journal of sports medicine2025
Glenoid Microfracture With or Without Arthroscopic Rotator Cuff Repair: Similar Rates of Return to Full Duty and Patient-Reported Outcome Measures Among Active-Duty Military Patients.
Article in Orthopaedic journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Arthroscopic Microfracture for Focal Glenoid Osteochondral Lesions in Young Active-Duty Military Patients: A Minimum 10-Year Follow-Up.Orthopaedic journal of sports medicine · 2026Article
- Outcomes After Microfracture for Concomitant Glenoid and Humeral Head Osteochondral Defects in Active-Duty Military Patients Younger Than 55 Years With Minimum 5-Year Follow-up.Orthopaedic journal of sports medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Concomitant arthroscopic rotator cuff repair (ARCR) and microfracture (MFX) for glenoid articular cartilage lesions among active-duty servicemembers yields lower return-to-duty rates than ARCR alone; however, there is no existing comparison with outcomes after MFX alone to elucidate where these discrepancies arise. Purpose: To compare postoperative outcomes and return-to-duty rates after MFX for glenoid cartilage lesions with and without ARCR. Study Design: Cohort study; Level of evidence, 3. Methods: Active-duty servicemembers 18 to 50 years of age who underwent either simultaneous ARCR/MFX or isolated MFX between January 2010 and August 2021 were eligible for inclusion if they had Outerbridge grade 4 glenoid articular cartilage lesions with or without full-thickness rotator cuff tears. All patients had at least 2 years of follow-up. Patient-reported outcome measures (PROMs), range of motion (ROM), return to duty, adverse events, and reoperations were collected and analyzed. Results: Ultimately, 38 patients were eligible for inclusion in the ARCR/MFX cohort and 28 in the MFX cohort, with higher mean age (42.5 vs 35.3 years, Conclusion: Patients undergoing MFX of glenoid articular cartilage defects with or without concomitant ARCR were found to have significant improvements in pain and PROMs, with very slight limitations in postoperative ROM observed among patients with concomitant ARCR. The results of this study suggest that active-duty military patients undergoing glenoid MFX with ARCR have similar final pain scores, PROMs, complication rates, and return-to-duty rates to patients undergoing MFX alone and can assist in preoperative counseling regarding military career management and postoperative expectations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.